B. J. Alps

550 total citations
28 papers, 472 citations indexed

About

B. J. Alps is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, B. J. Alps has authored 28 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in B. J. Alps's work include Receptor Mechanisms and Signaling (8 papers), Neuroscience and Neuropharmacology Research (7 papers) and Cardiac electrophysiology and arrhythmias (6 papers). B. J. Alps is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neuroscience and Neuropharmacology Research (7 papers) and Cardiac electrophysiology and arrhythmias (6 papers). B. J. Alps collaborates with scholars based in United Kingdom, Czechia and Canada. B. J. Alps's co-authors include M G Collis, AM Wilson, E S Johnson, William K. Hass, A.T. Kilpatrick, J. R. Holmes, Douglas E. McBean, Michael Spedding, J. M. Armstrong and James H. Holmes and has published in prestigious journals such as Neurology, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

B. J. Alps

28 papers receiving 378 citations

Peers

B. J. Alps
Norio Himori Japan
Concetta Harakal United States
George Glaubiger United States
AM Wilson United Kingdom
Ronald D. Robson Switzerland
Stephen J. Humphrey United States
G Lotti Italy
K. I. Melville Canada
M Gerold Switzerland
Ove A. Nedergaard Denmark
Norio Himori Japan
B. J. Alps
Citations per year, relative to B. J. Alps B. J. Alps (= 1×) peers Norio Himori

Countries citing papers authored by B. J. Alps

Since Specialization
Citations

This map shows the geographic impact of B. J. Alps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. J. Alps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. J. Alps more than expected).

Fields of papers citing papers by B. J. Alps

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. J. Alps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. J. Alps. The network helps show where B. J. Alps may publish in the future.

Co-authorship network of co-authors of B. J. Alps

This figure shows the co-authorship network connecting the top 25 collaborators of B. J. Alps. A scholar is included among the top collaborators of B. J. Alps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. J. Alps. B. J. Alps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alps, B. J., et al.. (1995). Reduction by lifarizine of the neuronal damage induced by cerebral ischaemia in rodents. British Journal of Pharmacology. 115(8). 1439–1446. 10 indexed citations
2.
McBean, Douglas E., et al.. (1995). Neuroprotective efficacy of lifarizine (RS‐87476) in a simplified rat survival model of 2 vessel occlusion. British Journal of Pharmacology. 116(8). 3093–3098. 25 indexed citations
3.
Alps, B. J., et al.. (1990). Prevention of myocardial enzyme release by ranolazine in a primate model of ischaemia with reperfusion. British Journal of Pharmacology. 99(1). 5–6. 46 indexed citations
4.
Alps, B. J., et al.. (1989). A comparison of the effects of a series of anti‐anginal agents in a novel canine model of transient myocardial ischaemia. British Journal of Pharmacology. 96(4). 977–985. 9 indexed citations
5.
Spedding, Michael, A.T. Kilpatrick, & B. J. Alps. (1989). ACTIVATORS AND INACTIVATORS OF CALCIUM CHANNELS: EFFECTS IN THE CENTRAL NERVOUS SYSTEM. Fundamental and Clinical Pharmacology. 3(S1). 3s–29s. 19 indexed citations
6.
Alps, B. J., et al.. (1988). The effects of the novel anti‐anginal compound RS 43285 on myocardial conduction in the anaesthetized dog. British Journal of Pharmacology. 93(2). 375–382. 14 indexed citations
7.
Alps, B. J., et al.. (1987). The effects of the novel anti-anginal agent RS 43285 on [lactic acid], [K+] and pH in a canine model of transient myocardial ischaemia. Biochemical Society Transactions. 15(6). 1057–1058. 20 indexed citations
8.
Alps, B. J., et al.. (1985). Striatal 5-hydroxytryptamine levels after experimental cerebral ischaemia. Biochemical Society Transactions. 13(2). 384–384. 1 indexed citations
9.
Wallach, Marshall B., B. J. Alps, Adolph P. Roszkowski, & L. David Waterbury. (1981). The neuro- and cardiovascular pharmacology of RS-51324, a potential antidepressant. Progress in Neuro-Psychopharmacology. 4(6). 569–584. 2 indexed citations
10.
11.
Alps, B. J., et al.. (1973). Further observations on the experimental antidysrhythmic activity of indoramin hydrochloride. Journal of Pharmacy and Pharmacology. 25(9). 700–704. 3 indexed citations
12.
Alps, B. J., et al.. (1973). Section A The pharmacology of lorazepam, a broad-spectrum tranquillizer. Current Medical Research and Opinion. 1(5). 239–261. 8 indexed citations
13.
14.
Alps, B. J., et al.. (1972). Quantitative analysis on isolated organs of the autonomic blocking properties of indoramin hydrochloride (Wy 21901). British Journal of Pharmacology. 44(1). 52–62. 36 indexed citations
15.
Alps, B. J., et al.. (1971). Synthesis and hypotensive activity of benzamidopiperidylethylindoles. Journal of Medicinal Chemistry. 14(11). 1054–1059. 16 indexed citations
16.
Alps, B. J., Melissa L. Hill, E S Johnson, & AM Wilson. (1970). Autonomic blocking properties of Wy 21901.. PubMed. 40(1). 153P–153P. 15 indexed citations
17.
Alps, B. J., E S Johnson, & AM Wilson. (1970). Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent.. PubMed. 40(1). 151P–152P. 21 indexed citations
18.
Alps, B. J., et al.. (1968). E.C.G. and tricyclic antidepressive drugs.. BMJ. 3(5620). 743.1–743. 5 indexed citations
19.
Holmes, J. R. & B. J. Alps. (1967). Studies into equine electrocardiography and vectorcardiography. 3. Vector distribution in some cardiovascular disorders.. PubMed. 31(8). 207–12. 3 indexed citations
20.
Alps, B. J., et al.. (1966). The effect of exercise on rhythm irregularities in the horse. Veterinary Record. 78(20). 672–683. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norio Himori Breakdown of academic impact, for papers by Concetta Harakal Breakdown of academic impact, for papers by George Glaubiger Breakdown of academic impact, for papers by AM Wilson Breakdown of academic impact, for papers by Ronald D. Robson Breakdown of academic impact, for papers by Stephen J. Humphrey Breakdown of academic impact, for papers by G Lotti Breakdown of academic impact, for papers by K. I. Melville Breakdown of academic impact, for papers by M Gerold Breakdown of academic impact, for papers by Ove A. Nedergaard
Rankless by CCL
2026